Company intelligence / Profile preview

AcryMed

Beaverton, Oregon, United States

Ownership: Private
Development stage: Other

Overview

AcryMed was a medical technology company focused on the development and commercialization of advanced silver-based antimicrobial technologies for wound care and medical devices. The company's core platform, SilvaGard, utilized nanotechnology to apply a thin, silver-based antimicrobial coating to various medical devices to prevent infections. AcryMed also developed and marketed products for chronic and acute wound management. In 2007, the company was acquired by Smith & Nephew, which integrated AcryMed's silver technologies into its global wound management portfolio.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: Medical DeviceSilver-based antimicrobial coating
Industry: Consumable Medical Devices

Partnerships

Smith & NephewC. R. Bard

Beyond the preview

Go deeper on AcryMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AcryMed.

Explore the full profile